Tag

JDD Webinars Archives - JDDonline - Journal of Drugs in Dermatology

Treating Acne in Adolescents and Young Adults

By Acne, JDD Webinars No Comments

JDD Multimedia

JDD Webinars

Register Now to Earn 1.0 CE Credit! 

Sign Up Now!

Treating Acne in Adolescents and Young Adults

Featuring Leon H. Kircik, MD, Anthony J. Mancini, MD, FAAP, FAAD, Adelaide A. Hebert, MD

Space Is Limited - Sign Up Now

Sign Up Now!

Earn 1.0 CE Credit:

Join Drs. Leon H. Kirick, Anthony Mancini, and Adelaide Hebert, as they  explore the categorization and grading of acne by age of onset in children and adolescents. They will also review and discuss new and evolving acne treatment strategies that offer optimal outcomes in children and young adults presenting with acne.

Upon completion of this live, internet-based CE activity, participants should be able to:

  • Appreciate the updated pediatric care classification, including appropriate evaluations and treatment, when needed 
  • Review acne treatment strategies offering optimal outcomes for pre-adolescents and adolescents with acne.

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Anthony J. Mancini, MD, FAAP, FAAD
Head, Division of Dermatology, Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine
Chicago, Illinois
Adelaide A. Hebert, MD
Chief of Pediatric Dermatology
McGovern School of Medicine
Childrens’ Memorial Hermann Hospital
Houston, Texas
Sign Up Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Thinning Hair Through Menopause: Results of a First-of-its-Kind Randomized Controlled Trial on Nutraceuticals

By Webinars on Demand No Comments

JDD Multimedia

JDD Webinars

Originally aired on February 9th, 2021, this Webcast features Dr. Glynis Ablon who discusses age and menopause related hair changes. She also presents results from two studies on the clinical benefits of standardized nutraceuticals on hair in women going through the menopausal transition and beyond.

Supported By

Nutrafol

 

Thinning Hair Through Menopause: Results of a First-of-its-Kind Randomized Controlled Trial on Nutraceuticals

Featuring Dr. Glynis Ablon, MD, FAAD

Watch On Demand

We understand that hair loss and thinning is an accumulation of multiple factors, this presentation will focus on hair thinning during menopause and results from a first-of-its-kind randomized controlled trial on nutraceuticals.

Originally aired on February 9th, 2021, this Webcast features Dr. Glynis Ablon who discusses age and menopause related hair changes. She also presents results from two studies on the clinical benefits of standardized nutraceuticals on hair in women going through the menopausal transition and beyond.

Faculty

Glynis Ablon, MD, FAAD
Ablon Skin Institute and Research Center

 

Watch on Vimeo

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Recognizing Nuances in the Diagnosis & Management of Acne in Skin of Color Patients

By Acne, JDD Webinars, Skin of Color No Comments

JDD Multimedia

JDD Webinars

Register Now to Earn 1.0 CE Credit! 

Sign Up Now!

Recognizing Nuances in the Diagnosis & Management of Acne in Skin of Color Patients

Featuring Leon Kircik, MD & Andrew Alexis, MD, MPH

Space Is Limited - Sign Up Now

Sign Up Now!

Earn 1.0 CE Credit:

Join Dr. Leon H. Kircik and Andrew Alexis, MD, MPH as they discuss they nuances in the diagnosis and management of acne in skin of color patients.

Upon completion of this enduring, internet-based webinar, participants should be able to:

  • Summarize the role of androgen and androgen receptors in the development and management of acne in skin of color patients
  • Recognize clinical nuances in acne grade and severity in skin of color patients
  • Differentiate therapeutic approaches in treating acne in patients with darker skin vs. lighter skin
  • Discuss new therapies in development for the management of acne

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Andrew Alexis, MD, MPH
Chair, Department of Dermatology
Mount Sinai West and Mount Sinai Morningside
Professor, Icahn School of Medicine at Mount Sinai
New York, New York
Sign Up Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Thinning Hair Through Menopause: Results of a First-of-its-Kind Randomized Controlled Trial on Nutraceuticals

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

In this free live webinar, Dr. Glynis Ablon will discuss age and menopause related hair changes and she will present results from two studies on the clinical benefits of standardized nutraceuticals on hair in women going through the menopausal transition and beyond.

Register Now

Register Now!
Supported By

 

Thinning Hair Through Menopause: Results of a First-of-its-Kind Randomized Controlled Trial on Nutraceuticals

Featuring Dr. Glynis Ablon

Register Now

Register Now!

We understand that hair loss and thinning is an accumulation of multiple factors, this presentation will focus on hair thinning during menopause and results from a first-of-its-kind randomized controlled trial on nutraceuticals.

Dr. Glynis Ablon will discuss age and menopause related hair changes and she will present results from two studies on the clinical benefits of standardized nutraceuticals on hair in women going through the menopausal transition and beyond.

Faculty

Glynis Ablon, M.D., FAAD

Glynis Ablon, M.D., FAAD, is a dermatologist and cosmetic surgeon, and Associate Clinical Professor of Dermatology at UCLA. She founded the Ablon Skin Institute and Research Center 20 years ago in Manhattan Beach, where in addition to a thriving medical and cosmetic practice, she guides pioneering research in dermatology products and procedures. Dr. Ablon is a Fellow of the American Academy of Dermatology, American Academy of Liposuction Surgery, American Society for Laser Medicine and Surgery, and American Society for Dermatologic Surgery, while on staff at Providence Little Company of Mary Medical Center and UCLA. She has also appeared as an on-camera medical consultant for the Emmy Award Winning The Doctors television show, as well as Entertainment Tonight, ABC, NBC, CBS, KCAL and Lifetime.

 

In her book What’s Stressing Your Face: A Skin Doctor’s Guide to Healing Stress-Induced Facial Conditions, Dr. Ablon provides comprehensive evaluations of case stories and her own personal experience of skin conditions and their relationships to stress in our daily lives. Her talk, What’s Stressing Your Face, will address how stress, facial skin problems, and age related conditions can show up, and offers effective healing methods combining holistic techniques and cutting-edge products and procedures to treat, control and reduce these conditions. Learn techniques to take control of your stress before it takes control of your skin.

 

Register Now!

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Watch On Demand: Proper Hydration and Exfoliation Support Treatments for Patients with Inflammatory Skin Conditions

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

Watch On Demand

This exclusive #SkinChat webinar originally aired on December 16th, 2020. Dr. Leon H. Kircik and Professor Petra Staubach-Renz  discussed the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

Proper hydration and exfoliation support treatments for patients with inflammatory skin conditions

By Heather Onorati

People with conditions characterized by an impaired skin barrier and hyperkeratosis can benefit from incorporating a uniquely formulated skincare regimen with other recommended treatments, according to two experts who shared insights into how a variety of ingredients work to complement therapeutic selections and improve outcomes for these patients. 

In a recent webinar, Professor Petra Staubach-Renz, department of dermatology, University Medical Center, Mainz, Germany, and Leon H. Kircik, M.D., Icahn School of Medicine at Mount Sinai, New York, delivered very relevant presentations on adjunctive skincare solutions for hyperkeratolytic conditions.

Dry, rough, uneven skin is a common symptom for many of these hyperkeratolytic conditions, according to Prof. Staubach-Renz. This is characterized by a build-up of cells on the skin’s surface that create an irregular, thick texture. Hyperkeratosis commonly presents in patients with conditions like keratosis pilaris, ichythyosis, psoriasis, and atopic dermatitis.  

More than 40% of people around the world suffer from keratosis pilaris, also called follicular keratosis, Prof. Staubach-Renz noted. In addition, there are more than 125 million people globally who suffer from psoriasis, 60% of which report that the disease significantly affects their lives, Dr. Kircik added. The biggest problems that those affected report are the appearance of the skin and the scaling, which result from transepidermal water loss and a dysfunctional epidermal barrier, he explained. 

Dry, rough, uneven skin is a common symptom for many of these hyperkeratolytic conditions, according to Prof. Staubach-Renz. This is characterized by a build-up of cells on the skin’s surface that create an irregular, thick texture. Hyperkeratois commonly presents in patients with conditions like keratosis pilaris, ichythyosis, psoriasis, and atopic dermatitis.  

According to Prof. Staubach-Renz, this is important to understand in order to treat the skin with the proper basic therapy. There are several critical components, and those include mild exfoliation with keratolytics and an occlusive moisturizer. 

Keratolytics break down the outer layers of the skin, which ultimately allow for other topical therapeutics like corticosteroids to penetrate, Dr. Kircik explained. Often, people who are prescribed topical corticosteroid treatments will complain they are unsatisfied and that the treatment is not working. 

“This is where the keratolytics come into the picture, Dr. Kircik said. Compounds like urea and salicylic acid break down that thick skin and allow the topical medication to penetrate. 

Pairing this activity with humectants and an occlusive will support repair of the epidermal barrier by allowing the skin to attract and then retain moisture.  

One over-the-counter skincare system that utilizes this combination of ingredients in a unique timed-release delivery system demonstrated both efficacy and tolerability in two studies cited by Prof. Staubach-Renz, which examined their use in the treatment of keratosis pilaris. 

Researchers found in one study that patients experienced a decrease in transepidermal water loss 1 hour following use of both a cleanser and cream, cell turnover time accelerated at 3-5 days, and 9 of 10 patients subjectively agreed that the skin felt softer, smoother and more comfortable after week 4. In a second study, the severity of dryness, texture and erythema began to improve at two weeks on dermatologic exam. At 8 weeks, skin dryness was reduced by 76%, and there was a visual improvement in roughness and erythema.

 

 

 

 

Heather Onorati is an experienced medical writer and editor with more than 20 years covering the dermatology industry.

 

 

 

 

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Adjunctive Skincare Solutions for Hyperkeratotic Skin Conditions, Including Keratosis Pilaris and Psoriasis

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

This #SkinChat orignally aired on December 16th, 2020. Tune in as Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

Supported By

CeraVe #SkinChat

 

Adjunctive Skincare Solutions for Hyperkeratotic Skin Conditions, Including Keratosis Pilaris and Psoriasis

Featuring Leon Kircik, MD & Prof. Petra Staubach-Renz

Watch On Demand

Join the JDD & CeraVe for this exclusive, on-demand #SkinChat webcast, where Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

This presentation  also includes relevant clinical data supporting the need for ceramides and skin barrier restoration regarding these Keratolytic skin conditions.

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Prof. Petra Staubach-Renz
Senior Physician Dermatology and Allergy
Managing Director, Clinical Research Centre,
Department of Dermatology, University Medical Center
Mainz, Germany
Watch on Vimeo

You May Also Like

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Rocking the Red: A Rosacea Research and Real World Roundup

| Podcast Highlights, Rosacea | No Comments
iTunes Google Play Stitcher TuneIn Dr. Richard Gallo & Dr. Adam Friedman   Rosacea is a complex, chronic inflammatory skin disease that is certainly not rockin for those who suffer…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

NEW Webinar – What’s New in Acne Management: What We Have Learned from Increased Understanding of Acne Pathophysiology

By JDD Webinars No Comments

Featured Article

Featured Webinar

Join Leon H. Kircik, MD; Linda Stein Gold, MD;  and Jonathan S. Weiss, MD as they discuss the medical interventions that target one or more of the key factors contributing to the development of acne lesions.

  • November 10th, 2020
  • 7:00 PM – 8:00 PM EST
Register Now!

Join Leon H. Kircik, MD; Linda Stein Gold, MD;  and Jonathan S. Weiss, MD as they discuss the medical interventions that target one or more of the key factors contributing to the development of acne lesions.

Acne pathogenesis is multifactorial and not clearly understood; a key factor includes genetics and may result as in interplay of release of inflammatory mediators into the skin, follicular hyperkeratinization with subsequent plugging of the follicle, Cutibacterium acne (C. acnes), formerly Propionibacterium acnes or P. acnes, follicular colonization and excess sebum production.

C. acnes has been shown to mediate inflammatory processes at the site of the sebaceous follicle contributing to the formation of free radical species and generating pro-inflammatory cytokines. Excess sebum production and
C. acnes colonization lead to the formation of microcomedones leading to the development of open or closed comedones, inflammatory papules, pustules and cysts characteristic of acne.
Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), skin current skin care regimen are
factors influencing treatment with classes of topical agents include: comedolytic (anticomedogenic), antimicrobial, antibiotic and antiinflammatory; each impact on the four main pathogenic features of acne.
Join Drs. Leon H. Kircik, Linda Stein Gold, and Jonathan S. Weiss as they discuss the medical interventions generally targeting one or more of the key factors contributing to the development of acne lesions: follicular hyperproliferation and abnormal desquamation (topical and oral retinoids, azelaic acid, salicylic acid, hormonal therapy), increase sebum production (oral isotretinoin, hormonal therapy), C. acnes proliferation (benzoyl peroxide, topical and oral antibiotics, azelaic acid) and inflammation (oral isotretinoin, oral tetracyclines, topical retinoids, azelaic acid).
Register Now!

You May Also Like

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

February issue highlights new perspectives in chronic skin conditions

| Acne, Aesthetics, Featured Articles, JDD Highlights | No Comments
It’s a hopeful time of year, and the articles published in this month’s issue underscore this hope and transition with researchers bringing forward new perspectives on chronic skin conditions like…

NEW Webinar – Differentiating Approach to Acne Therapy: Women Vs. Men

By JDD Webinars No Comments

Featured Article

Featured Webinar

Join Leon H. Kircik, MD and Julie Harper, MD as they discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris.

  • October 27th, 2020
  • 7:00 PM – 8:00 PM EST
Register Now!

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and
treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.
Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.
Register Now!

You May Also Like

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

February issue highlights new perspectives in chronic skin conditions

| Acne, Aesthetics, Featured Articles, JDD Highlights | No Comments
It’s a hopeful time of year, and the articles published in this month’s issue underscore this hope and transition with researchers bringing forward new perspectives on chronic skin conditions like…

Premiere Webinar Event: Recognizing the Role of The Sebaceous Gland in Acne

By JDD Webinars No Comments

Featured Article

Featured Webinar

Join Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD as they discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris.

Register Now!

Join Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD as they discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris.

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Register Now!

You May Also Like

Experts Offer Recommendations for Use of Absorbable Suspension Sutures

| Aesthetics, Featured Articles, Psoriasis, The Latest | No Comments
Used alone, absorbable suspension sutures offer a dual mechanism of action Used alone, absorbable suspension sutures offer a dual mechanism of action Heather Onorati As the use of absorbable suspension…

In Support of a More Useful Definition for ‘Moderate’ Psoriasis

| Featured Articles, The Latest | No Comments
Successful psoriasis treatment is dependent upon accurate assessment of disease severity; however, a recent survey indicates that dermatologists report a wide variation in cutoffs for moderate disease classification on traditional…

February issue highlights new perspectives in chronic skin conditions

| Acne, Aesthetics, Featured Articles, JDD Highlights | No Comments
It’s a hopeful time of year, and the articles published in this month’s issue underscore this hope and transition with researchers bringing forward new perspectives on chronic skin conditions like…

COVID-19: Special Considerations for the Skin of Color Patient – A Conversation with the Experts

By COVID-19 Webinars No Comments

JDD Multimedia

COVID-19: Special Considerations for the Skin of Color Patient – A Conversation with the Experts

Watch Now

This webinar was previously recorded on April 27th, 2020 and is now available on demand.

Skin of Color Update (SOCU) and JDD invite you to attend “COVID-19: Special Considerations for the Skin of Color Patient – A Conversation with the Experts”. During this 90-minute webinar, Dr. Andrew Alexis will be joined by skin of color key opinion leaders to discuss special considerations and practical approaches to managing dermatologic disorders in skin of color during the COVID-19 pandemic.
Topics to be addressed include the following:
  • Hair Disorders
  • Pigmentary Disorders
  • Aesthetic Concerns
  • Inflammatory Disorders (including acne, atopic dermatitis, psoriasis, and others)
  • How to stay connected with your skin of color patients on social media
  • Vitamin D deficiency among people of color and its potential relevance to COVID-19 in patients of color
  • COVID-19 related shifts in common dermatologic concerns in skin of color
  • Impact on the practice of aesthetic dermatology for skin of color
MODERATOR: 
  • Andrew Alexis, MD, MPH (Chair, Department of Dermatology, Mount Sinai West and Mount Sinai Morningside and Professor, Icahn School of Medicine at Mount Sinai)
PANELISTS:
  • Eliot F. Battle, Jr., MD (CEO and Co-Founder of Cultura Dermatology & Plastic Surgery)
  • Amy McMichael, MD (Professor and Chair of Dermatology, Wake Forest Baptist Medical Center)
  • Heather Woolery-Lloyd, MD (Director, Skin of Color Division, University of Miami School of Medicine)
  • Pearl Grimes, MD (Founder and Director, Vitiligo and Pigmentation Institute of Southern California)
Watch Now

You May Also Like

COVID-19 WebinarsJDD WebinarsSkin Barrier Function
August 5, 2020

View on Demand: Restoring Skin Barrier Function – Why Formulation Matters

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin. Tune in as Professor Michael J. Cork BSC…
COVID-19 WebinarsJDD WebinarsSkin Barrier Function
July 14, 2020

Free Webinar: Restoring Skin Barrier Function: Why Formulation Matters

Thursday, July 23rd 2020 12:00 pm EST Space is limited - secure your spot today! With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential,…
COVID-19 WebinarsJDD Webinars
July 1, 2020

View on Demand Now: Systemic and Local Effects of Stress on the Hair Follicle

Dr. Suneel Chilukuri presents both the systemic and local effects of stress on the hair follicle in this on-demand-video. Supported by Since we understand that hair loss and thinning is…
Next Steps in Derm COVID Resource Center

COVID-19: Resource Center hosted by Next Steps in Dermatology

By Next Steps Webinars No Comments

JDD Multimedia

COVID-19: Resource Center hosted by Next Steps in Dermatology

Next Steps in Derm COVID Resource Center

Next Steps in Derm COVID-19 News & Resources Center offers a carefully curated selection of relevant news and resources from truthworthy sources to help physicians navigate the COVID-19 pandemic.

View Resources Now

You May Also Like

COVID-19 WebinarsJDD WebinarsSkin Barrier Function
August 5, 2020

View on Demand: Restoring Skin Barrier Function – Why Formulation Matters

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin. Tune in as Professor Michael J. Cork BSC…
COVID-19 WebinarsJDD WebinarsSkin Barrier Function
July 14, 2020

Free Webinar: Restoring Skin Barrier Function: Why Formulation Matters

Thursday, July 23rd 2020 12:00 pm EST Space is limited - secure your spot today! With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential,…
COVID-19 WebinarsJDD Webinars
July 1, 2020

View on Demand Now: Systemic and Local Effects of Stress on the Hair Follicle

Dr. Suneel Chilukuri presents both the systemic and local effects of stress on the hair follicle in this on-demand-video. Supported by Since we understand that hair loss and thinning is…
COVID-19 Resident Derm In-Review JDD Residency

COVID-19: The Resident and Program Director Perspective

By COVID-19 Webinars No Comments

JDD Multimedia

COVID-19: The Resident and Program Director Perspective

COVID-19 Resident Derm In-Review JDD Residency
Watch Now
JDD, Derm In-Review and GW invite you to join Dermatology colleagues and as we answer resident concerns during the global coronavirus pandemic. Discussions include the date of the boards, being redeployed into other units, working on non-emergency skin conditions in clinics and many more questions submitted by your colleagues.

The live webinar was broadcasted on April 22nd, 2020 thanks to the support of the sponsors mentioned in the webinar.

 

MODERATORS

Adam Friedman, MD (Professor and Interim Chair of Dermatology, GW School of Medicine & Health Sciences )
Misty Eleryan, MD (Chief Dermatology Resident, GW School of Medicine & Health Sciences)

PANELISTS

  • Erin Mathes, MD (Program Director, UCSF School of Medicine)
  • Michael Waul, MD (Chief Resident, UCSF School of Medicine)
  • Courtney Reynolds Schadt, MD (Program Director, University of Louisville School of Medicine)
  • Meg Wetzel, MD (Chief Resident, University of Louisville School of Medicine)
  • Sarah Robinson, MD (Associate Program Director, Tufts University School of Medicine)
  • Brooke Rothstein, MD (Chief Resident, Tufts University School of Medicine)
  • Holly Kerr, MD (Program Director, Henry Ford Health System)
  • Angad Chadha, MD (Chief Resident, Henry Ford Health System)

SPECIAL GUESTS

  • Emily Hejazi, MD (Resident, Albert Einstein College of Medicine/Montefiore Medical Center)
  • Kim Campbell (Founder, Dermatology Authority)

HOSTED BY

  • JDD
  • Derm In-Review
  • GW School of Medicine & Health Sciences
Watch Now

You May Also Like

COVID-19 WebinarsJDD WebinarsSkin Barrier Function
August 5, 2020

View on Demand: Restoring Skin Barrier Function – Why Formulation Matters

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin. Tune in as Professor Michael J. Cork BSC…
COVID-19 WebinarsJDD WebinarsSkin Barrier Function
July 14, 2020

Free Webinar: Restoring Skin Barrier Function: Why Formulation Matters

Thursday, July 23rd 2020 12:00 pm EST Space is limited - secure your spot today! With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential,…
COVID-19 WebinarsJDD Webinars
July 1, 2020

View on Demand Now: Systemic and Local Effects of Stress on the Hair Follicle

Dr. Suneel Chilukuri presents both the systemic and local effects of stress on the hair follicle in this on-demand-video. Supported by Since we understand that hair loss and thinning is…